|
Neogenomics, Inc. - Company Profile Snapshot
| Company Profile: |
Neogenomics, Inc. |
| Ticker: |
NGNM |
| Exchanges: |
OTC |
| 2008 Sales: |
20,015,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED STATES |
| Employees: |
114 |
Business Description
Neogenomics, Inc.. The Group's principal activity is to operate cancer-focused testing laboratories to provide testing services to pathologists, oncologists, urologists, hospitals, and other laboratories throughout the United States . Its testing services include cytogenetics testing, which analyzes human chromosomes; Fluorescence In-Situ Hybridization (FISH) testing, which analyzes abnormalities at the chromosomal and gene levels; flow cytometry testing, which analyzes gene expression of specific markers inside cells and on cell surfaces; immunohistochemistry testing, which analyzes the distribution of tumor antigens in specific cell and tissue types and molecular testing which involves analysis of DNA and RNA to diagnose and predict the clinical significance of various genetic sequence disorders.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
